Enzymatica AB (publ) (STO:ENZY)

Enzymatica AB Statistics

Total Valuation

Enzymatica AB has a market cap or net worth of SEK 606.84 million. The enterprise value is 581.44 million.

Market Cap	606.84M
Enterprise Value	581.44M

Important Dates

The last earnings date was Tuesday, April 14, 2026.

Earnings Date	Apr 14, 2026
Ex-Dividend Date	n/a

Share Statistics

Enzymatica AB has 242.74 million shares outstanding. The number of shares has increased by 14.72% in one year.

Current Share Class	242.74M
Shares Outstanding	242.74M
Shares Change (YoY)	+14.72%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	7.14%
Owned by Institutions (%)	13.34%
Float	106.48M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	11.44
PB Ratio	5.47
P/TBV Ratio	12.85
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-12.28
EV / Sales	10.96
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-14.72

Financial Position

The company has a current ratio of 3.05, with a Debt / Equity ratio of 0.01.

Current Ratio	3.05
Quick Ratio	2.09
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	-0.02
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -35.22% and return on invested capital (ROIC) is -21.62%.

Return on Equity (ROE)	-35.22%
Return on Assets (ROA)	-18.99%
Return on Invested Capital (ROIC)	-21.62%
Return on Capital Employed (ROCE)	-42.34%
Weighted Average Cost of Capital (WACC)	2.23%
Revenue Per Employee	2.65M
Profits Per Employee	-2.37M
Employee Count	21
Asset Turnover	0.34
Inventory Turnover	1.26

Taxes

In the past 12 months, Enzymatica AB has paid 406,000 in taxes.

Income Tax	406,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -16.33% in the last 52 weeks. The beta is -0.37, so Enzymatica AB's price volatility has been lower than the market average.

Beta (5Y)	-0.37
52-Week Price Change	-16.33%
50-Day Moving Average	2.49
200-Day Moving Average	2.23
Relative Strength Index (RSI)	41.72
Average Volume (20 Days)	92,793

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Enzymatica AB had revenue of SEK 53.06 million and -47.34 million in losses. Loss per share was -0.20.

Revenue	53.06M
Gross Profit	31.10M
Operating Income	-46.95M
Pretax Income	-46.93M
Net Income	-47.34M
EBITDA	-44.48M
EBIT	-46.95M
Loss Per Share	-0.20

Balance Sheet

The company has 26.06 million in cash and 661,000 in debt, with a net cash position of 25.40 million or 0.10 per share.

Cash & Cash Equivalents	26.06M
Total Debt	661,000
Net Cash	25.40M
Net Cash Per Share	0.10
Equity (Book Value)	110.89M
Book Value Per Share	0.46
Working Capital	35.17M

Cash Flow

In the last 12 months, operating cash flow was -39.19 million and capital expenditures -305,000, giving a free cash flow of -39.49 million.

Operating Cash Flow	-39.19M
Capital Expenditures	-305,000
Depreciation & Amortization	2.47M
Net Borrowing	-1.45M
Free Cash Flow	-39.49M
FCF Per Share	-0.16

Margins

Gross margin is 58.61%, with operating and profit margins of -88.48% and -89.21%.

Gross Margin	58.61%
Operating Margin	-88.48%
Pretax Margin	-88.45%
Profit Margin	-89.21%
EBITDA Margin	-83.82%
EBIT Margin	-88.48%
FCF Margin	n/a

Dividends & Yields

Enzymatica AB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-14.72%
Shareholder Yield	-14.72%
Earnings Yield	-7.80%
FCF Yield	-6.51%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2